Solicitation of Nominations for Appointment to the Board of Scientific Counselors (BSC), National Institute for Occupational Safety and Health (NIOSH), 7056-7057 [2019-03666]
Download as PDF
7056
Federal Register / Vol. 84, No. 41 / Friday, March 1, 2019 / Notices
Board of Governors of the Federal Reserve
System, February 26, 2019.
Ann Misback,
Secretary of the Board.
[FR Doc. 2019–03687 Filed 2–28–19; 8:45 am]
BILLING CODE 6210–01–P
GENERAL SERVICES
ADMINISTRATION
[Notice–PBS–2018–07; Docket No. 2018–
0002; Sequence No. 21]
Redesignation of Federal Building
Public Buildings Service (PBS),
General Services Administration (GSA).
ACTION: Notice of a bulletin.
AGENCY:
SUMMARY: The attached bulletin
announces the redesignation of a
Federal building per the Federal
Management Regulation.
DATES: This bulletin expires September
3, 2019. The building redesignation
remains in effect until canceled or
superseded by another bulletin.
FOR FURTHER INFORMATION CONTACT:
General Services Administration, Public
Buildings Service (PBS), Office of
Portfolio Management, Attn: Chandra
Kelley, 77 Forsyth Street SW, Atlanta,
GA 30303, at 404–562–2763, or by email
at chandra.kelley@gsa.gov.
SUPPLEMENTARY INFORMATION:
This bulletin announces the
redesignation of a Federal building.
Public Law 115–141, Section 632, dated
January 3, 2017, designated the Jackson
Federal Courthouse, located at 501 East
Court Street in Jackson, Mississippi, as
the ‘‘Thad Cochran United States
Courthouse.’’
Dated: February 22, 2019.
Emily W. Murphy,
Administrator of General Services.
GENERAL SERVICES
ADMINISTRATION
jbell on DSK30RV082PROD with NOTICES
REDESIGNATION OF FEDERAL
BUILDING
PBS-2018-07
TO: Heads of Federal Agencies.
SUBJECT: Redesignation of Federal
Building.
1. What is the purpose of this
bulletin? This bulletin announces the
redesignation of a Federal building.
2. When does this bulletin expire?
This bulletin announcement expires
September 3, 2019. The building
designation remains in effect until
canceled or superseded by another
bulletin.
3. Redesignation. The former and new
name of the redesignated building is as
follows:
VerDate Sep<11>2014
18:13 Feb 28, 2019
Jkt 247001
Former name
New name
Jackson Federal
Courthouse, 501
East Court Street in
Jackson, Mississippi, 39201.
Thad Cochran United
States Courthouse,
501 East Court
Street in Jackson,
Mississippi, 39201.
4. Who should we contact for further
information regarding redesignation of
this Federal building? U.S. General
Services Administration, Public
Buildings Service, Office of Portfolio
Management, Attn: Chandra Kelley, 77
Forsyth Street, SW, Atlanta, GA 30303,
telephone number: 404-562-2763, or email at chandra.kelley@gsa.gov.
Dated: February 22, 2019.
Emily W. Murphy,
Administrator of General Services.
[FR Doc. 2019–03711 Filed 2–28–19; 8:45 am]
BILLING CODE 6820–Y1–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Board of Scientific
Counselors (BSC), National Institute
for Occupational Safety and Health
(NIOSH)
ACTION:
Notice.
SUMMARY: The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
BSC, NIOSH. The BSC, NIOSH consists
of 15 experts in fields associated with
occupational safety and health.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of
occupational medicine, occupational
nursing, industrial hygiene,
occupational safety and health
engineering, toxicology, chemistry,
safety and health education,
ergonomics, epidemiology, biostatistics,
and psychology. Federal employees will
not be considered for membership.
Members may be invited to serve for up
to four-year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of the BSC,
NIOSH objectives https://www.cdc.gov/
niosh/BSC/default.html.
DATES: Nominations for membership on
the BSC, NIOSH must be received no
later than April 30, 2019. Packages
received after this time will not be
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to NIOSH Docket 278, c/o
Pauline Benjamin, Committee
Management Specialist, National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention, 1600 Clifton Rd. NE, MS: E–
20, Atlanta, Georgia 30329 or emailed
(recommended) to nioshdocket@
cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Alberto Garcia, M.S., Designated Federal
Officer, CDC/NIOSH, 1090 Tusculum
Ave. MS R–5, Cincinnati, OH 45226,
telephone (513) 841–4596; agarcia1@
cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for BSC, NIOSH membership each year,
and provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in January, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE Nominees must be
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D Cover letter, including a description
of the candidate qualifications and why
the candidate would be a good fit for the
BSC.
E:\FR\FM\01MRN1.SGM
01MRN1
Federal Register / Vol. 84, No. 41 / Friday, March 1, 2019 / Notices
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–03666 Filed 2–28–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3376–N]
Medicare Program; Solicitation of
Independent Accrediting Organizations
To Participate in the Home Infusion
Therapy Supplier Accreditation
Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
jbell on DSK30RV082PROD with NOTICES
AGENCY:
SUMMARY: This notice informs national
accrediting organizations that accredit
home infusion therapy suppliers of an
opportunity to submit applications to
participate in the home infusion therapy
supplier accreditation program. This
notice contains information on how to
apply for CMS approval.
DATES: Complete applications will be
considered for the January 1, 2021
designation deadline if received at the
address, provided in the ADDRESSES
section of this notice, by 5 p.m. eastern
daylight time (e.d.t.) on February 1,
2020.
ADDRESSES: Applications should be sent
to: Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, Maryland 21244. Mail stop
C2–21–16, Attention: Christina MisterWard.
FOR FURTHER INFORMATION CONTACT:
Christina Mister-Ward (410) 786–2441.
VerDate Sep<11>2014
18:13 Feb 28, 2019
Jkt 247001
SUPPLEMENTARY INFORMATION:
I. Background
Section 1861(iii)(1) of the Social
Security Act (‘‘the Act’’) defines ‘‘home
infusion therapy’’ as the items and
services described furnished by a
qualified home infusion therapy
supplier which are furnished in the
individual’s home. The individual must
be—
• Under the care of an applicable
provider; and
• With respect to whom a plan
prescribing the type, amount, and
duration of infusion therapy services
that are to be furnished such individual
has been established by a physician and
is periodically reviewed by a physician
in coordination with the furnishing of
home infusion drugs under part B.
According to section 1861(iii)(3)(A) of
the Act, ‘‘Applicable provider’’ means a
physician, a nurse practitioner, or a
physician assistant. In accordance with
section 1834(u)(5) of the Act, we
defined ‘‘National accrediting
organization’’ at 42 CFR 488.1005 as an
organization that accredits provider or
supplier entities under a specific
program and whose accredited provider
or supplier entities under each program
are widely dispersed geographically
across the United States. In addition, the
specific program is active, fully
implemented, and operational.
In the November 13, 2018 Federal
Register (83 FR 56406),we published a
final rule titled, ‘‘Medicare and
Medicaid Programs; CY 2019 Home
Health Prospective Payment System
Rate Update and CY 2020 Case-Mix
Adjustment Methodology Refinements;
Home Health Value-Based Purchasing
Model; Home Health Quality Reporting
Requirements; Home Infusion Therapy
Requirements; and Training
Requirements for Surveyors of National
Accrediting Organizations.’’ The
November 2018 final rule implemented
health and safety standards that home
infusion therapy suppliers must meet;
the temporary transitional payments for
home infusion therapy services for CYs
2019; and an approval and oversight
process for accrediting organizations
(AOs) that accredit home infusion
therapy suppliers. For more detailed
information on the home therapy
organization accreditation requirements
see the November 2018 final rule (83 FR
56563 through 56584).
Section 1861(iii)(3)(D)(i)(III) of the
Act, as added by section 5012(b) of the
21st Century Cures Act, requires that a
home infusion therapy supplier be
accredited by an AO designated by the
Secretary in accordance with section
1834(u)(5) of the Act. Section
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
7057
1834(u)(5)(A) of the Act identifies
factors for designating AOs and
modifying the list of designated AOs.
These statutory factors are as follows:
• The ability of the organization to
conduct timely reviews of accreditation
applications.
• The ability of the organization take
into account the capacities of suppliers
located in a rural area (as defined in
section 1886(d)(2)(D) of the Act).
• Whether the organization has
established reasonable fees to be
charged to suppliers applying for
accreditation.
• Such other factors as the Secretary
determines appropriate.
Section 1834(u)(5)(B) of the Act
requires the Secretary to designate AOs
to accredit home infusion therapy
suppliers furnishing home infusion
therapy not later than January 1, 2021.
II. Provisions of the Notice
This notice solicits applications from
AOs with the ability to accredit home
infusion therapy suppliers.
A. Eligible Organizations
An accreditation organization that can
show evidence of the ability to accredit
qualified home infusion therapy
suppliers as defined in section
1861(iii)(3)(D)(i) of the Act are eligible
to apply for approval as a designated
accreditation organization.
To be considered for approval as a
Medicare-designated home infusion
therapy AO under 42 CFR part 488,
subpart L (§§ 488.1000 through
488.1050), an accrediting organization
must meet the following requirements:
• The AO must have a home infusion
therapy accreditation program that it
separates and distinguishes from any of
its other accreditation programs (if
applicable).
• The AO must have home infusion
therapy accreditation standards that
meet or exceed the Medicare home
infusion therapy health and safety
standards codified at §§ 486.500 through
486.525 of our regulations.
B. Application Requirements
To be considered for approval by
Medicare as a home infusion therapy
accrediting organization, an accrediting
organization must submit an application
to CMS requesting approval of its home
infusion therapy accreditation program.
The home infusion therapy accrediting
organization’s application must contain
all of the following information to
demonstrate that the AO’s home
infusion therapy accreditation program
meets or exceeds the applicable
Medicare requirements:
• Documentation to demonstrate that
they meet the definition of a ‘‘national
E:\FR\FM\01MRN1.SGM
01MRN1
Agencies
[Federal Register Volume 84, Number 41 (Friday, March 1, 2019)]
[Notices]
[Pages 7056-7057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03666]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Board of
Scientific Counselors (BSC), National Institute for Occupational Safety
and Health (NIOSH)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the BSC, NIOSH. The BSC, NIOSH
consists of 15 experts in fields associated with occupational safety
and health.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
committee's objectives. Nominees will be selected based on expertise in
the fields of occupational medicine, occupational nursing, industrial
hygiene, occupational safety and health engineering, toxicology,
chemistry, safety and health education, ergonomics, epidemiology,
biostatistics, and psychology. Federal employees will not be considered
for membership. Members may be invited to serve for up to four-year
terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of the BSC, NIOSH objectives https://www.cdc.gov/niosh/BSC/default.html.
DATES: Nominations for membership on the BSC, NIOSH must be received no
later than April 30, 2019. Packages received after this time will not
be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to NIOSH Docket 278, c/o
Pauline Benjamin, Committee Management Specialist, National Institute
for Occupational Safety and Health, Centers for Disease Control and
Prevention, 1600 Clifton Rd. NE, MS: E-20, Atlanta, Georgia 30329 or
emailed (recommended) to nioshdocket@cdc.gov.
FOR FURTHER INFORMATION CONTACT: Alberto Garcia, M.S., Designated
Federal Officer, CDC/NIOSH, 1090 Tusculum Ave. MS R-5, Cincinnati, OH
45226, telephone (513) 841-4596; agarcia1@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens, and cannot be full-time employees of
the U.S. Government. Current participation on federal workgroups or
prior experience serving on a federal advisory committee does not
disqualify a candidate; however, HHS policy is to avoid excessive
individual service on advisory committees and multiple committee
memberships. Committee members are Special Government Employees (SGEs),
requiring the filing of financial disclosure reports at the beginning
and annually during their terms. CDC reviews potential candidates for
BSC, NIOSH membership each year, and provides a slate of nominees for
consideration to the Secretary of HHS for final selection. HHS notifies
selected candidates of their appointment near the start of the term in
January, or as soon as the HHS selection process is completed. Note
that the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year. SGE Nominees must be U.S. citizens, and cannot be
full-time employees of the U.S. Government. Candidates should submit
the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
[ssquf] Cover letter, including a description of the candidate
qualifications and why the candidate would be a good fit for the BSC.
[[Page 7057]]
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities for both CDC and the Agency for Toxic Substances
and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-03666 Filed 2-28-19; 8:45 am]
BILLING CODE 4163-18-P